Barry S. Skikne
Direttore/Membro del Consiglio presso TVAX BIOM
Profilo
Barry S.
Skikne is an Independent Director at TVAX Biomedical, Inc. He previously worked as the Director-Bone Marrow Transplantation Program at the University of Kansas from 1993 to 2007.
Dr. Skikne completed his undergraduate degree at the University of the Witwatersrand and holds a doctorate degree from the University of South Africa.
Posizioni attive di Barry S. Skikne
| Società | Posizione | Inizio |
|---|---|---|
| TVAX BIOM | Direttore/Membro del Consiglio | 01/12/2011 |
Precedenti posizioni note di Barry S. Skikne
| Società | Posizione | Fine |
|---|---|---|
| University of Kansas | Corporate Officer/Principal | 01/07/2007 |
Formazione di Barry S. Skikne
| University of the Witwatersrand | Undergraduate Degree |
| University of South Africa | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
TVAX Biomedical, Inc.
 TVAX Biomedical, Inc. BiotechnologyHealth Technology TVAX Biomedical, Inc. manufactures and sells healthcare products. It is a biotechnology company, which focuses on the development of targeted cell-based immunotherapies for the treatment of cancer and is performing clinical trials with specific focus on brain cancers. The firm’s proprietary immunologic treatment, TVAX Immunotherapy, uses a patient's cells to create activated, genetically unique cancer-killing T cells that can destroy the patient's cancer cells, including cancer stem cells, which are widely believed to be responsible for cancer growth, spread and metastasis. The company was founded by Gray W. Wood, Frank P. Holladay, Catherine E. Lucasey and Lowell Lynn Tilzer on July 14, 2011 and is headquartered in Lenexa, KS. | Health Technology |
- Borsa valori
- Insiders
- Barry S. Skikne
